Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
3,037,675
-
Shares change
-
-1,004,843
-
Total reported value, excl. options
-
$109,582,279
-
Value change
-
-$50,151,759
-
Put/Call ratio
-
5.7%
-
Number of buys
-
28
-
Number of sells
-
-44
-
Price
-
$36.07
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2020
89 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q1 2020.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,037,675 shares
.
Largest 10 shareholders include MORGAN STANLEY (813,259 shares), GOLDMAN SACHS GROUP INC (617,716 shares), JPMORGAN CHASE & CO (586,899 shares), BANK OF AMERICA CORP /DE/ (174,457 shares), Wharton Business Group, LLC (127,281 shares), Financial Management Professionals, Inc. (75,603 shares), Brookstone Capital Management (68,176 shares), Hochman Cole Investment Advisors, Inc. (57,227 shares), FIRST CITIZENS BANK & TRUST CO (45,449 shares), and LPL Financial LLC (43,027 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.